Archive for September 2023

With two Big Pharmas abandoning partnerships and its only clinical-stage drug posting less-than-encouraging data, Waltham’s Morphic Therapeutic has had a rough couple of years. Read More

This Hispanic Heritage Month, El Planeta took the opportunity to converse with several Latinos working at the Massachusetts State House, highlighting their contributions and experiences. Read More

The Denmark drug giant will use Valo’s platform that uses real-world patient data and AI computation to speed up the delivery and development process. Read More

Organizations like Northeastern University and EforAll are expanding into Maine. There are already early signs of success, including a rise of VC funding in the state and the praise of local founders. Read More

"When it comes to AAPI representation, leadership, visibility and belonging, the arts play a really important role in terms of elevating and honoring and celebrating our identity, our heritage and our shared stories.” Read More

From The Conversation: Biases against Black-sounding first names can lead to discrimination in hiring, especially when employers make decisions in a hurry, new research shows. Read More

In an interview, Openly CEO Ty Harris explained that the Series D round will cover operations and also "feeds" the company’s balance sheet to keep up with the premium growth. Read More

A Woburn biotech behind antibodies for Covid-19, cancer and eye disease is set to go public by reverse-merging with a special-purpose acquisition company, or SPAC. Read More

"We believe that the long-term fundamentals for clean power resources are extremely strong." Read More

This week’s Playbook Edition looks at the IRS hitting pause on a lucrative tax credit, why leaning into strengths can boost gender diversity and more. Read More